Law360, New York (October 06, 2009) -- A judge has ruled that Sanofi-Aventis is bound to a settlement agreement it reached with Sun Pharmaceutical Industries Ltd. in a patent infringement suit over generic versions of Sanofi’s popular colon cancer drug Eloxatin, even though it failed to sign the agreement.
In an order handed down Friday, Judge Joel Pisano of the U.S. District Court of New Jersey ruled that the settlement was valid even though Sanofi did not return signed...
